From: Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
Baseline characteristics | ILD N = 23 | Donor explant controls N = 9 | Time FVC% to biopsy (months) |
---|---|---|---|
Age (years ± SD) | 60 ± 9.8 | 50 ± 7.8 |  |
Sex (male, N %) | 13 (57%) | 4 (44%) | Â |
Race | Â | Â | Â |
 White | 18 | 7 |  |
 Black | 5 | 2 |  |
Type of interstitial lung disease (N, (%)) | Â | Â | Â |
 Connective tissue disease | 12 (52) |  | 2.25 \(\pm 1.75\) |
 Unclassifiable | 6 (26) |  | 2.83 \(\pm 1.20\) |
 Smoking-related | 4 (17) |  | 1.55 \(\pm 0.95\) |
Hypersensitivity pneumonitis | 1 (4) | Â | 1.8 |